V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210029973 | 210009265 | 0 | 85 | Palliative (P) | 2015-10-24 | 2015-11-02 | UKALL14- Ph 2 Induction + Imatinib | Y | N | 210018243 | UKALL2014 |
| 210029974 | 210009268 | 1.75 | 84.4 | Curative (C) | 2015-01-24 | 2015-03-10 | UKALL14- Maintenance | Y | null | 210018253 | UKALL2014 |
| 210029975 | 210009271 | 1.84 | 82 | Curative (C) | 2015-06-07 | 2015-08-28 | UKALL 14 TRIAL | N | N | 210018261 | UKALL2014 |
| 210029976 | 210009273 | 1.93 | 84.4 | Curative (C) | 2015-05-13 | 2015-10-25 | UKALL 14 TRIAL | 1 | N | 210018264 | UKALL2014 |
| 210029977 | 210030790 | 1.83 | 74.5 | Neo-adjuvant (N) | 2014-06-30 | 2014-06-30 | UKALL14- Maintenance | 02 | Y | 210018266 | UKALL2014 |
| 210029978 | 210019877 | 1.71 | 66.9 | Curative (C) | 2014-01-08 | 2014-07-03 | UKALL 14 TRIAL | N | N | 210018273 | UKALL2014 |
| 210029979 | 210009279 | 1.75 | 108.55 | Curative (C) | 2015-02-23 | 2015-02-23 | UKALL14- Cons Cycle 3 | 01 | N | 210018276 | UKALL2014 |
| 210029980 | 210019879 | 1.73 | 50.7 | Palliative (P) | 2015-11-21 | 2015-11-21 | UKALL14- Maintenance | Y | N | 210018278 | UKALL2014 |
| 210029981 | 210009285 | 1.57 | 74 | Curative (C) | 2017-08-06 | 2017-08-06 | UKALL14- Ph 2 Induction | Y | null | 210018281 | UKALL2014 |
| 210029982 | 210009287 | 1.73 | 96.6 | Curative (C) | 2017-08-04 | 2017-09-04 | UKALL14- Maintenance | 02 | N | 210018288 | UKALL2014 |
| 210029984 | 210009293 | null | 52.7 | Curative (C) | 2017-02-11 | 2017-03-27 | UKALL14- Maintenance | 02 | N | 210018303 | UKALL2014 |
| 210029985 | 210019887 | 1.82 | null | Curative (C) | 2014-08-21 | 2015-01-08 | UKALL14- Ph 2 Induction | 01 | N | 210018316 | UKALL2014 |
| 210029986 | 210009296 | 1.77 | 82.5 | Curative (C) | 2017-10-27 | 2017-11-24 | UKALL14- Cons Cycle 1 | 1 | null | 210018321 | UKALL2014 |
| 210029987 | 210009300 | 1.94 | 78.8 | Curative (C) | 2016-05-16 | 2016-09-24 | UKALL 14 TRIAL | N | N | 210018324 | UKALL2014 |
| 210029988 | 210009302 | 1.75 | 74.6 | Curative (C) | 2018-01-14 | 2018-01-22 | UKALL14- Ph 2 Induction | 02 | N | 210018334 | UKALL2014 |
| 210029989 | 210019894 | 1.77 | 91.5 | Adjuvant (A) | 2013-07-30 | 2013-08-05 | UKALL14- Cons Cycle 2 | N | Y | 210018336 | UKALL2014 |
| 210029990 | 210009307 | 1.67 | 92 | Palliative (P) | 2018-05-08 | 2018-10-03 | UKALL14- Intens/CNS Proph | 02 | N | 210018337 | UKALL2014 |
| 210029992 | 210009310 | 1.88 | 97.6 | Disease modification (D) | 2014-03-29 | 2014-08-09 | UKALL14- Maintenance | Y | N | 210018343 | UKALL2014 |
| 210029993 | 210009311 | 1.67 | 79 | Palliative (P) | 2013-06-02 | 2013-07-10 | UKALL14- Maintenance | 01 | N | 210018353 | UKALL2014 |
| 210029994 | 210009317 | 1.75 | 106.3 | Curative (C) | 2016-05-18 | 2016-05-18 | UKALL14- Maintenance | N | N | 210018363 | UKALL2014 |
| 210029996 | 210009321 | null | 87.3 | Curative (C) | 2014-10-29 | 2014-10-30 | UKALL14- Cons Cycle 2 | Y | null | 210018371 | UKALL2014 |
| 210029997 | 210019903 | null | 80.7 | Curative (C) | 2013-06-30 | 2013-08-06 | UKALL14- Maintenance + Imatinib | 2 | N | 210018378 | UKALL2014 |
| 210029998 | 210009324 | 1.65 | 82.5 | Curative (C) | 2017-09-24 | 2017-10-28 | UKALL14- Ph 2 Induction | N | null | 210018380 | UKALL2014 |
| 210029999 | 210009328 | 1.79 | 78 | Curative (C) | 2018-03-01 | 2018-03-01 | UKALL14- Intens/CNS Proph | Y | N | 210018384 | UKALL2014 |
| 210030000 | 210009329 | null | 114 | Curative (C) | null | 2016-07-13 | UKALL14- Maintenance | Y | N | 210018385 | UKALL2014 |
| 210030001 | 210009331 | 1.85 | 83.2 | Curative (C) | null | 2015-12-01 | UKALL14- Intens/CNS Proph | Y | null | 210018399 | UKALL2014 |
| 210030002 | 210009333 | 1.64 | 52.7 | Disease modification (D) | 2015-01-02 | 2015-01-15 | UKALL14- Maintenance | 2 | null | 210018405 | UKALL2014 |
| 210030003 | 210009335 | null | null | Curative (C) | 2017-01-19 | 2017-01-28 | UKALL14- Cons Cycle 3 | N | null | 210018405 | UKALL2014 |
| 210030004 | 210019912 | 1.76 | null | Curative (C) | 2015-02-01 | 2015-06-08 | UKALL14- Intens/CNS Proph | N | N | 210018415 | UKALL2014 |
| 210030005 | 210009338 | 1.82 | 79.9 | Curative (C) | 2013-08-22 | 2013-10-04 | UKALL14- Ph 2 Induction + Imatinib | Y | null | 210018415 | UKALL2014 |
| 210030006 | 210019914 | 1.74 | null | Curative (C) | null | 2014-02-24 | UKALL14- Maintenance + Imatinib | N | N | 210018417 | UKALL2014 |
| 210030007 | 210009341 | 1.78 | 92 | Adjuvant (A) | null | 2012-12-09 | UKALL 14 TRIAL | 2 | N | 210018421 | UKALL2014 |
| 210030008 | 210009341 | null | 64 | Curative (C) | 2013-11-03 | 2013-11-07 | UKALL14- Ph 1 Induction | 02 | N | 210018421 | UKALL2014 |
| 210030009 | 210009342 | 1.75 | 65.1 | Curative (C) | 2014-01-05 | 2014-02-16 | UKALL14- Cons Cycle 3 | null | N | 210018435 | UKALL2014 |
| 210030010 | 210009345 | null | 94.2 | Curative (C) | 2013-09-02 | 2013-09-02 | UKALL14- Maintenance | 02 | null | 210018446 | UKALL2014 |
| 210030011 | 210009346 | 1.71 | 74 | Palliative (P) | 2016-04-20 | 2016-04-20 | UKALL14- Maintenance + Imatinib | N | null | 210018447 | UKALL2014 |
| 210030012 | 210009347 | 1.72 | 60.2 | Adjuvant (A) | 2016-06-13 | 2016-10-17 | UKALL14- Maintenance | N | N | 210018450 | UKALL2014 |
| 210030013 | 210009350 | 1.69 | 91.8 | Curative (C) | 2015-01-16 | 2015-01-16 | UKALL14- Intens/CNS Proph +Imatinib | 01 | N | 210018451 | UKALL2014 |
| 210030014 | 210009354 | 0 | 78 | Palliative (P) | 2013-12-10 | 2013-12-21 | UKALL14- Intens/CNS Proph | 02 | N | 210018458 | UKALL2014 |
| 210030015 | 210019927 | 1.68 | 72.6 | Disease modification (D) | 2014-12-28 | 2014-12-28 | UKALL14- Maintenance | 1 | N | 210018466 | UKALL2014 |
| 210030016 | 210009359 | 1.84 | 90.7 | Curative (C) | 2015-09-24 | 2015-12-21 | UKALL14- Ph 1 Induction + Imatinib | Y | null | 210018475 | UKALL2014 |
| 210030017 | 210009361 | 1.77 | 115 | null | 2017-11-10 | 2017-12-08 | UKALL14- Intens/CNS Proph +Imatinib | N | N | 210018484 | UKALL2014 |
| 210030018 | 210026750 | 1.64 | 84.6 | Curative (C) | 2014-03-10 | 2014-03-17 | UKALL14- FMC (2 day) Conditioning | N | null | 210018489 | UKALL2014 |
| 210030019 | 210009366 | 1.65 | 53 | Curative (C) | 2017-05-22 | 2017-07-04 | UKALL14- Maintenance | N | N | 210018494 | UKALL2014 |
| 210030021 | 210009375 | 1.62 | 69.7 | Adjuvant (A) | 2017-12-13 | 2017-12-25 | UKALL14- Ph 2 Induction | Y | N | 210018518 | UKALL2014 |
| 210030022 | 210009379 | 1.71 | 143.8 | Curative (C) | 2017-11-05 | 2017-11-07 | UKALL14- Ph 2 Induction + Imatinib | 1 | N | 210018537 | UKALL2014 |
| 210030023 | 210009381 | 1.82 | null | Curative (C) | 2013-07-20 | 2013-10-17 | UKALL14- Cons Cycle 1 + Imatinib | 02 | N | 210018538 | UKALL2014 |
| 210030024 | 210009382 | 1.68 | 61 | Curative (C) | null | 2015-09-08 | UKALL14- Maintenance + Imatinib | N | Y | 210018556 | UKALL2014 |
| 210030025 | 210009384 | 1.77 | 67.1 | Disease modification (D) | 2017-08-06 | 2017-08-14 | UKALL14- Intens/CNS Proph +Imatinib | N | N | 210018557 | UKALL2014 |
| 210030026 | 210009387 | 1.77 | 91.5 | Curative (C) | 2015-08-11 | 2016-01-19 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210018559 | UKALL2014 |